SYGNIS completes acquisition of TGR Biosciences
May 8, 2018
Heidelberg, Germany and Cambridge, UK – SYGNIS AG (Frankfurt: LIO1; ISIN: DE000A1RFM03; Prime Standard) today announced the completion of the acquisition of TGR Biosciences (TGR), the Australian research reagents company. TGR and its highly complementary technologies and products along with its strong customer base will significantly contribute to the overall performance of the SYGNIS Group. SYGNIS is currently [...]
Greiner Bio-One acquires 3D Cell Culture Technology assets from Nano3D Biosciences, Inc.
May 8, 2018
Greiner Bio-One Magnetic 3D Cell Culture Products Greiner Bio-One North America, Inc. has acquired 3D Cell Culture Technology previously owned by Nano 3D Biosciences, Inc. As an international distributor of these products since 2016, Greiner Bio-One has now taken the initiative to become a premier provider of this technology worldwide. Magnetic 3D cell culture has [...]
US FDA Procures DILIsym Software License Package
May 8, 2018
DILIsym Services, Inc., a Simulations Plus company (NASDAQ: SLP) and a leading provider of simulation and modeling software for pharmaceutical safety, today announced that the U.S. Food and Drug Administration has secured an annual government license for its flagship QSP (quantitative systems pharmacology) modeling software, DILIsym®. DILIsym is the product of an ongoing public-private partnership (the [...]
ASPECT BIOSYSTEMS RECEIVES $1M INVESTMENT FROM GENOME BC
May 7, 2018
Genome BC Invests $1 million in Funding to Top Canadian 3D Bioprinting Company Aspect Biosystems Vancouver, Canada — Genome BC is pleased to announce $1 million in funding to Aspect Biosystems (Aspect), a privately held biotechnology company focused on commercializing cutting-edge 3D bioprinting technologies. Aspect’s Lab-on-a-Printer™ 3D bioprinting platform technology enables the rapid creation of functional [...]
May 7, 2018
Cambridge, UK and Deqing, China -- Abcam, a global leader in the supply of life science research tools, today signed a Memorandum of Understanding (MoU) with Shuwen Biotech, a leading player in the development and commercialization of companion diagnostics (CDx). Through the agreement, Abcam and Shuwen will jointly leverage their respective capabilities, in producing high-quality antibodies and CDx kit [...]
Agilent Completes Acquisition of Lasergen, Inc.
May 7, 2018
SANTA CLARA, Calif.--Agilent Technologies Inc. (NYSE: A) today announced that it has completed the acquisition of Lasergen, Inc. (Lasergen), an emerging biotechnology company focused on research and development of innovative technologies for DNA sequencing. In March 2016 Agilent made an initial investment in the Houston, Texas based privately-held company to acquire a 48-percent ownership stake with [...]
Porvair Sciences Makes Strategic Appointment for US Microplate Business
May 7, 2018
Porvair Sciences and J.G. Finneran Associates are pleased to announce the appointment of Bob Brino as OEM Business Development Manager for their microplate and sample prep product lines. Bob comes to Porvair-Finneran with twenty years’ experience in microplate design, manufacture and marketing across North America with Greiner Bio-One. As a Biology Major from Temple University, [...]
New Leica Microsystems Reference Site is first of its kind in Israel
May 7, 2018
A new partnership between Leica Microsystems and Bar-Ilan University, Ramat-Gan, Israel is officially in place Wetzlar, Germany. Leica Microsystems are pleased to announce a new collaboration with the Bar-Ilan University, Ramat-Gan, Israel. The new agreement aims to promote and establish Bar-Ilan as a new reference site for Leica products and workflows. As part of the [...]
May 7, 2018
TUCSON, Ariz. and HUNINGUE, France -- HTG Molecular Diagnostics, Inc. (Nasdaq:HTGM) (“HTG”), a provider of instruments, reagents and services for molecular profiling applications, and Firalis S.A. (“Firalis”), a provider of bioanalytical services and biomarker-based products and services, today announced a non‑exclusive license and supply agreement (“Agreement”) that will enable Firalis to commercialize a next‑generation sequencing (NGS)‑based theranostic [...]
New Thermo Scientific Prisma SEM Combines Performance and Versatility
May 7, 2018
New Prisma has the simplicity and speed required for industrial applications and the advanced capabilities needed for research HILLSBORO, Ore. – Scientists working in industrial and academic R&D, quality control, and failure analysis laboratories now have access to a simple but powerful new scanning electron microscope (SEM) that also offers a full range of imaging and [...]

